The QualityStocks Daily Thursday, January 31st, 2019

Today's Top 3 StockMarketWatch

QualityStocks (TMSR) +96.83%

PennyStockProphet (SCYX) +41.67%

StockMarketWatch (FBIO) +39.86%

The QualityStocks Daily Stock List

Concierge Technologies, Inc. (CNCG)

Light Speed Stocks, Epic Stock Picks, Nebula Stocks, MicrocapVoice, OTCPicks, PennyStocks24, Pumps and Dumps, ProTrader, EpicVIP Group, MomentumOTC, OnPointStockAlert, Penny Stock Prodigy, Penny Stock Titans, The Street, and TopPennyStockMovers reported previously on Concierge Technologies, Inc. (CNCG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Concierge Technologies, Inc. is a global conglomerate with operating businesses in financial services, food manufacturing, beauty products and security systems. The Company has facilities located in the U.S.A., New Zealand, and Canada. Concierge Technologies has its head office in Valley Center, California. The Company’s shares trade on the OTC Markets’ OTCQB.

Concierge Technologies operates through its wholly-owned subsidiaries - Original Sprout, Wainwright Holdings, Gourmet Foods, Ltd., and Brigadier Security Systems. In addition, USCF is a subsidiary of the Company. USCF operates at the frontline of product innovation as an asset management firm offering exchange-traded products (ETPs), exchange-traded funds (ETFs), as well as mutual funds.

Gourmet Foods is a well-established producer of popular New Zealand meat pies and bakery products under recognized supermarket brand names “Pat’s Pantry” and “Ponsonby Pies”. Gourmet Foods products are in convenience stores, major supermarkets, petroleum stations, and restaurants. Gourmet Foods distributes greater than 30 products throughout New Zealand.

Concierge Technologies’ Brigadier Security Systems of Saskatoon, Saskatchewan is an alarm installation and monitoring company. It is a long-standing security alarm business serving the Province of Saskatchewan since 1985. Brigadier has security solutions ranging from products designed to protect residential premises and property through to complex access control and camera monitoring equipment. Brigadier Security Systems operates under the trade name Elite Security.

The Original Sprout subsidiary is a California-based manufacturer and international distributor of natural, 100 percent vegan, hair and skin care products. Master hair stylist Inga Tritt founded Original Sprout in 2003.

This month, Concierge Technologies announced that its wholly-owned subsidiary, Original Sprout, launched a new, updated, website at www.originalsprout.com. Original Sprout is best known for its natural hair and body wash formulated for babies. However, this subsidiary’s product line has grown to include styling products for adults, such as protein hair mist, hair gel, reef safe sun block, shampoos and conditioners, and many more.

Mr. Michael Ambacher, Chief Operating Officer of Original Sprout, said, ''Original Sprout products are clinically tested by independent laboratories and are confirmed hypoallergenic, non-allergenic, cruelty-free and reef safe. Our new website highlights these attributes with fresh images and updated content. We are excited to get our message out and are looking forward to 2019 as a year we make significant progress in underserved market segments.''

Concierge Technologies, Inc. (CNCG), closed Thursday's trading session at $1.02, even for the day. The average volume for the last 3 months is 214 and the stock's 52-week low/high is $0.55/$1.85.

chart

CTD Holdings, Inc. (CTDH)

HotStockChat, Capital Cube, Dividend Investor, Greenbackers, Wall Street Resources, Marketwired, Pink Investing, YCharts, Nebula Stocks, The Street, 4-Traders, Business Insider, Guru Focus, Penny Stock Hub, Financial Content, Research Pool, Morningstar, Market Screener, and Wallet Investor reported earlier on CTD Holdings, Inc. (CTDH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

CTD Holdings, Inc. is developing cyclodextrin-based products for the treatment of disease. This includes Trappsol® Cyclo™. The Company’s other divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies engaged in the research, pharmaceutical, medical device, cosmetics, and nutrition markets. CTD Holdings is headquartered in Alachua, Florida.

The Company’s Trappsol® Cyclo™ is an orphan drug designated product. It is for the treatment of Niemann-Pick Type C (NPC). NPC impacts the brain, lung, liver, spleen, as well as other organs. Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. This includes peripheral artery disease, diabetic nephropathy, and acute viral infections.

CTD Holdings’ other divisions operate the world's only cGMP pulse drying facility to produce UltraPure™ cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. Furthermore, they supply cyclodextrins to biotechnology and life science researchers internationally from the world's largest catalog of cyclodextrins.

CTD Holdings has started a multi-center worldwide Phase I/II clinical trial in Europe. This clinical trial is evaluating intravenous administration of Trappsol® Cyclo™ in NPC patients.

CTD Holdings announced in November 2018 its newest partner in support of its U.S. clinical program, Synteract. Synteract is a full-service Clinical Research Organization, which has an existing relationship with CTD in support of its Phase I/II clinical trial at sites in Israel and Sweden. Synteract will support CTD’s Extension Protocol, “An Open-Label Extension Study of the Long-Term Safety and Efficacy of Intravenous Trappsol® Cyclo™ (HPBCD) in Patients with Niemann-Pick Disease Type C (NPC-1),” in the U.S.

This month, CTD Holdings announced its newest partner in support of its U.S. clinical program, United BioSource LLC (UBC). UBC provides pharmaceutical and home nursing services in support of clinical trials and other patient-centered initiatives. UBC will support CTD’s above-mentioned Extension Protocol.

CTD’s Extension Protocol for the Phase I trial was approved by the Food and Drug Administration (FDA) in April of 2018. The Protocol allows eligible subjects who have completed the Phase I trial in the U.S. to continue to receive intravenous administration of the Company’s Trappsol® Cyclo™, CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, until market registration.

CTD Holdings, Inc. (CTDH), closed Thursday's trading session at $0.79, up 5.33%, on 4,527 volume with 5 trades. The average volume for the last 3 months is 14,914 and the stock's 52-week low/high is $0.25/$1.179.

chart

Gopher Protocol, Inc. (GOPH)

Epic Stock Picks, Zacks, Green Leaf Pot Stocks, Market News Updates, Penny Stock Scholar, InvestorsHub, MarketWatch, Investing, Penny Trader, Profitable Trader Authority, Morningstar, GuruFocus, TradingView, Wall Street Mover, OTCtipReporter and Integrity Solution IR reported previously on Gopher Protocol, Inc. (GOPH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. The Company provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features. Its Integrated Circuit (IC), named GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. The system is self-learning and continually developing. Gopher Protocol is based in Santa Monica, California.

Gopher Protocol is developing a real-time, heuristic based, mobile technology. Upon development, this mobile technology will consist of a smart microchip, mobile application software, and supporting software that run on a server. The system foresees the establishment of a worldwide network. The heart of this system will be its advanced microchip, which will be able to undergo installation in any mobile device.

Gopher Protocol has its licensed technology, the Guardian Patch. The Guardian Patch is a stick-on tracking device. The Guardian Patch device was conceived as an offshoot of its microchip technology GopherInsight™. The mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System).

Gopher Protocol is working to integrate its Guardian Patch radio technology within its digital coin Blockchain system. The Company has received its Guardian Patch patent and filed a non-provisional patent for its cryptocurrency system. Gopher Protocol is incorporating its gEYE security engine into its digital currency Technology Platform, the GRC.

In addition, the Company has its "dDrone" technology. This technology utilizes Artificial Intelligence (AI) to create what is believed to be the world's first" Smart Drone." Gopher AI drone technology uses machine learning to give drones advanced flight capabilities.

Gopher Protocol’s Avant! AI is an Artificial Intelligence system, neural network based, targeted to manage and supervise the Company’s technologies. Avant! is structured to provide context to the huge volume of unstructured data in the world today. Its goal is enhancing human and machine capability. It can respond to highly complex situations and quickly provide a wide spectrum of potential responses and recommendations that are backed by evidence it has analyzed. Its basis is advanced reasoning and learning systems.

Earlier this month, Gopher Protocol announced it is implementing distributed artificial intelligence (DAI) methodologies within its Avant! AI system. The Company has completed its DAI working model for its Avant! AI system and is now in the implementation stage.

Mr. Danny Rittman, Ph.D., Gopher Protocol’s Chief Technology Officer, stated, "This type of technology is important in order to enable Avant!'s parallel processing when necessary. In multi-user environment, a large scale computation and resources distribution is needed in order to provide vast solutions and answers. Avant! DAI is a smart system and will be activated only when needed in certain situations. We completed Avant!'s DAI working model, which we believe to be robust and elastic."

Gopher Protocol, Inc. (GOPH), closed Thursday's trading session at $0.3903, down 2.42%, on 315,299 volume with 130 trades. The average volume for the last 3 months is 433,351 and the stock's 52-week low/high is $0.289/$4.85.

chart

IntelGenx Technologies Corp. (IGXT)

Wolf Street, Equity Clock, Market Screener, last10k, InvestorsHub, Zacks, Morningstar, Streetwise Reports, Stock Invest, MarketWatch, Stockhouse, GuruFocus, YCharts, Wallet Investor, and Real Investment Advice reported earlier on IntelGenx Technologies Corp. (IGXT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

IntelGenx Technologies Corp. is a foremost oral drug delivery company listed on the OTC Markets’ OTCQX. It mainly centers on the development and manufacturing of unique pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. The Company’s state-of-the-art manufacturing facility, constructed for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, providing full service capabilities to its clients. IntelGenx Technologies has its corporate office in Saint-Laurent, Quebec.

The VersaFilm™ and VetaFilm™ rapidly disintegrating thin polymeric film technologies improve drug performance. Additionally, they ease administration without the requirement for water. IntelGenx Technologies states that the VersaFilm™ and VetaFilm™ products have the potential to enhance bioavailability, accelerate onset of action, reduce side effects and ease administration, thus improving patients’ compliance and satisfaction.

The Company’s highly skilled team provides wide-ranging pharmaceuticals services to pharmaceutical partners. These services include research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Furthermore, IntelGenx’s VetaFilm™ consists of R&D services for veterinary oral film technology.

Last week, IntelGenx provided an update on its Phase 2a study of Montelukast VersaFilm™ in patients with mild to moderate Alzheimer’s Disease (AD). So far, seven study sites across Canada have randomized eight subjects, many of which started dosing in late-2018. IntelGenx Technologies sponsored study sites are actively screening for new patients. In addition to opening its planned eighth trial site, the Company is preparing to open an additional site in Montreal, bringing the total number of sites to nine.

Yesterday, IntelGenx Technologies announced that the U.S. Food and Drug Administration (FDA) performed a Pre-Approval Inspection (PAI) of the Company’s Health Canada-certified cGMP manufacturing facility in Montreal, Quebec. The PAI is related to the IntelGenx New Drug Application (NDA) for RIZAPORT®, a VersaFilm™ oral soluble film for the treatment of acute migraines.

At the conclusion of the PAI on January 25, 2019, the FDA issued a Form 483 with five inspectional observations. The FDA assigned a Prescription Drug User Fee Act goal date of April 1, 2019, for completion of the review of the resubmitted NDA for RIZAPORT®.

IntelGenx Technologies Corp. (IGXT), closed Thursday's trading session at $0.72, up 7.46%, on 722,435 volume with 297 trades. The average volume for the last 3 months is 414,855 and the stock's 52-week low/high is $0.43/$1.83.

chart

Sports Field Holdings, Inc. (SFHI)

RedChip, Real Investment Advice, Investors Hub, Marketwired, Simply Wall St, The Street, Zacks, Market Screener, Stockhouse, Stockopedia, Barchart, Wallet Investor, Innovative Marketing, MarketWatch, and Marketbeat reported earlier on Sports Field Holdings, Inc. (SFHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sports Field Holdings, Inc. engages in the design, engineering, and construction of eco-safe athletic facilities. The Company, by way of its wholly-owned subsidiary, FIRSTFORM, Inc., is a product development, engineering and design-build construction business. Sports Field considers itself a leader in innovative playing surfaces that focus on player safety and high performance athletic fields. OTCQB-listed, Sports Field Holdings has its head office in St. Charles, Illinois.

Sports Field engages in the design, engineering, construction, and construction management of athletic fields and sports complexes. In addition, the Company supplies its proprietary, technologically advanced, synthetic turf products and systems to the industry. Its two principal lines of business are construction management of sports facilities and synthetic turf sales. Sports Field says that these two lines of business can be categorized as design, development, and manufacturing of sports surfacing products and associated pre-engineered construction systems.

The Company’s FIRSTFORM® subsidiary supplies its proprietary patent-pending products, athletic field systems, and knowledge-based services to the athletic construction industry. For customers, a FIRSTFORM® Architect will customize their design plan. Additionally, a FIRSTFORM® Design Engineer will create their drainage plan. A FIRSTFORM® Project Manager will also manage the entire construction process.

Sports Field Holdings has its "PrimePlay" crumb rubber-free line of synthetic turf products. The Company’s flagship PrimePlay™ products are available and undergoing installation in athletic facilities across the U.S.  Sports Field’s PrimePlay® Replicated Grass is crafted to closely mirror natural grass. It has a blade density almost three times greater than conventional artificial turf.

Sports Field also has its Primetrack Accel™ product line. This product features polyurethane derived from premium raw materials and secure traction and optimal slip protection. Primetrack Accel™ also features optimal force absorption, spike resistance, and is available in full range of color options. Primetrack Accel™ also features a uniform, consistent surface with durable performance.

Sports Field Holdings, Inc. (SFHI), closed Thursday's trading session at $0.50, down 9.09%, on 22,520 volume with 9 trades. The average volume for the last 3 months is 3,385 and the stock's 52-week low/high is $0.061/$0.65.

chart

Where Food Comes From, Inc. (WFCF)

NetworkNewsWire, Wyatt Investment Research, MicroCapClub, The Bowser Report, Marketbeat, Market Exclusive, SmallCapVoice, OTC Markets, Stockopedia, and The Street reported earlier on Where Food Comes From, Inc. (WFCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Where Food Comes From, Inc. is a trusted resource for third party verification of food production practices. The Company supports greater than 10,000 farmers, ranchers, processors, retailers, distributors, and restaurants with a wide assortment of value-added services through its IMI Global, International Certification Services, Validus Verification Services, Sterling Solutions, A Bee Organic, and SureHarvest units. Where Food Comes From is based in Castle Rock, Colorado and lists on the OTCQB.

Where Food Comes From has a solutions portfolio that covers beef, pork, poultry, lamb, dairy, eggs, and organic. The Company’s solutions portfolio includes offerings ranging from source and age, non-hormone and humane handling to organic, non-GMO (Genetically Modified Organism) and gluten free.

The Where Food Comes From retail and restaurant labelling program uses the verification of product attributes to connect consumers to the sources of the food they buy through product labelling and web-based information sharing and education. Utilizing QR code technology, consumers’ can rapidly access information pertaining to the producers behind their food.

The Company has a 60 percent interest in privately held SureHarvest, Inc. SureHarvest is a leading provider of agri-food sustainability solutions. SureHarvest provides a broad array of sustainability and farming MIS solutions, certification and compliance management, and a host of professional services.

A Bee Organic is a USDA Accredited Certification Agency. A Bee Organic provides customers with National Organic Program (NOP) certifications for hydroponic, aquaponic, in-ground, and wild crops. This includes avocados, blueberries, citrus and stone fruits, greens, as well as manzanita.

Where Food Comes From’s Validus Verification Services is a leader in independent certification of socially responsible production practices covering pork, poultry, and dairy products. Validus Verification Services is a wholly-owned subsidiary of Where Food Comes From.  

The Company’s wholly-owned subsidiary Sterling Solutions is a top provider of third-party verification services in the western United States. Sterling Solutions serves large dairies, calf ranches, and cattle operations. It has greater than 10 years of on-farm auditing experience.

Recently, Where Food Comes From announced it has been named Program Administrator for the new U.S. Hemp Authority™ Certified verification standard.  With this agreement, the Company’s Validus Verification Services unit was named as exclusive certification body for hemp growers and processors looking to comply with the standard and earn the right to display the U.S. Hemp Authority™ Certified seal in their product labeling, advertising and marketing.

Where Food Comes From, Inc. (WFCF), closed Thursday's trading session at $1.89, up 2.16%, on 970 volume with 5 trades. The average volume for the last 3 months is 7,421 and the stock's 52-week low/high is $1.75/$3.07.

chart

Wrap Technologies, Inc. (WRTC)

Stockflare, Wall Street Pennies, Simply Wall St, Investors Hangout, Trading View, Investing News Alerts, VentureLine, High Rising Stocks, Stockhouse, Stockwatch, Jet Life Penny Stocks, Street Insider, and Penny Stock Hub reported on Wrap Technologies, Inc. (WRTC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Wrap Technologies, Inc. is an innovator of modern policing solutions. The Company premiered its hand-held BolaWrap™ 100 remote restraint solution at the International Association of Police Chiefs (IACP) October 2017 international conference. The Company’s technology assists law enforcement and military in safely and effectively controlling encounters. Wrap Technologies is headquartered in Las Vegas, Nevada.

The BolaWrap 100 is a restraint tool for Police and Military. It can be used early in an encounter between officer and suspect to prevent unnecessary escalation and violence. BolaWrap 100 is light and operable by an officer using support hand. Remote restraint helps in controlling subjects.

The design of BolaWrap 100 is to remotely restrain without uncontrolled falls. The BolaWrap™ 100 is a hand-held remote restraint device. It discharges an eight-foot bola style Kevlar tether to entangle an individual at a range of 10-25 feet. BolaWrap 100 features speedy cartridge refresh to support numerous wraps. The design of the product is to safely and effectively control encounters by remotely wrapping a subject's legs, limiting the need for potentially injurious less lethal or lethal force. Wrap Technologies’ pilot demonstration program has resulted in the delivery of BolaWrap 100 products to more than 45 agencies in the last seven months.

Wrap Technologies has launched the BolaWrap "Train the Trainer" program in partnership with select law enforcement agencies. The design of the program is to facilitate deployment of BolaWrap 100 to law enforcement officers in the field. The Train the Trainer sessions are held at large departments or central locations with attendance by trainers from several local departments.

The Company has also introduced and is progressing to launching its new BolaWrap green line laser innovation. The BolaWrap100 Line Laser is a compact green line laser sight. The design of it is exclusively for the BolaWrap Model 100 remote restraint device. The inventive accessory allows the user to precisely target the intended wrapping location with a distinct green line.

Last week, Wrap Technologies reported that it hosted an invitation only demonstration of its first product, the BolaWrap 100, to over 25 representatives from distributors from 10 different countries on Wednesday, January 23, 2019. The areas represented included North and South America, Europe and Asia.

Wrap Technologies, Inc. (WRTC), closed Thursday's trading session at $3.64, up 8.66%, on 69,004 volume with 176 trades. The average volume for the last 3 months is 40,445 and the stock's 52-week low/high is $2.09/$9.00.

chart

Novo Resources Corp. (NSRPF)

The Online Investor, OTC Markets, Insider Financial, Metals News, Streetwise Reports, 4-Traders, StockInvest, Energy and Gold, The OTC Reporter, Spotlight Growth, YCharts, Emerging Growth, Dividend Investor, Capital Cube, Investors Hangout, GuruFocus, Junior Mining Network, Mining Stock Valuator, Stockhouse, InvestorsHub, Finance Registrar, TradingView, and MarketWatch reported earlier on Novo Resources Corp. (NSRPF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Novo Resources Corp.’s focus is to evaluate, acquire, and explore gold properties. The Company’s present emphasis is to explore and develop gold projects in the Pilbara area of Western Australia. Novo has built up a substantial land package encompassing about 12,000 sq km. OTCQX-listed, Novo Resources is headquartered in Vancouver, British Columbia.

The Company also controls a 100 percent interest in roughly 2 sq kms covering much of the Tuscarora Au-Ag vein district in Nevada. Novo Resources’ present focus is its Beatons Creek and Marble Bar paleoplacer gold projects in Western Australia. The Company owns the approximately10 sq km Beatons Creek Tenements in Western Australia. Extensive test work conducted on Beatons Creek conglomerates indicates high gravity recoveries.

Novo Resources has the right to earn a 70 percent interest in the approximately 1,800 sq km Pilbara Paleoplacer Gold Project that includes the Beatons Creek and Marble Bar paleoplacer gold projects, in Western Australia from the Creasy Group. It has also acquired, by way of staking, a 100 percent interest in roughly 6,021 sq kms of mineral rights in the Karratha area.

Novo staked exploration applications encompassing roughly 7,000 sq kms in the area around Karratha. It controls approximately an additional 2,000 sq kms elsewhere in the Pilbara region.

Pertaining to the Karratha Gold Project, Novo Resources entered into farm-in and joint venture (JV) agreements with Artemis Resources to earn-in on an additional 1,256 sq kms of mineral rights. Novo also entered into sale and purchase agreements and farm-in and JV agreements for an 80 percent interest in the Comet Well property. The Company also entered into an option agreement for 100 percent of Welcome Exploration’s gold rights.

Recently, Novo Resources announced gold-rich assay results from concentrates generated by mechanical sorting trials conducted on four bulk samples from the Company’s Karratha gold project. Novo also announced encouraging gold recovery from its first terrace gravel bulk sample at Egina.

Mr. Rob Humphryson, Chief Executive Officer and Director of Novo Resources, said, “Concentrate grades received from the recent Tomra mechanical rock sorting trials are impressive, reflecting the capability of the scanning and sorting technology to differentially select gold bearing rock. Total system gold recovery efficiency will be fully understood upon receipt of assay results from all process streams and feed size ranges, with these results expected during January 2019.”

Novo Resources Corp. (NSRPF), closed Thursday's trading session at $1.965, down 1.56%, on 119,694 volume with 147 trades. The average volume for the last 3 months is 122,745 and the stock's 52-week low/high is $1.42/$5.00.

chart

Golden Matrix Group, Inc. (GMGI)

Tip Ranks, Stockflare, ClayTrader, Infront Analytics, InvestorsHub, Stockhouse, Penny Stock Tweets, Wallet Investor, Morningstar, MarketWatch, Investor Place, Penny Stock Hub, Barchart, GuruFocus, Real Investment Advice, Dividend Investor, Central Charts, Simply Wall St, YCharts, 4-Traders, last10k, and Capital Cube reported previously on Golden Matrix Group, Inc. (GMGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Golden Matrix Group, Inc. is an established gaming technology company headquartered in Las Vegas, Nevada. It develops and owns online gaming Intellectual Property (IP). In addition, Golden Matrix builds configurable and scalable white-label social gaming platforms for its worldwide customers, located primarily in the Asia Pacific region.

Fundamentally, Golden Matrix Group pioneers highly modular, configurable and scalable social gaming platforms for its global customers. The Company does so in an effort to promote user acquisition, engagement, retention, and monetization. In strict compliance with current United States law, Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the United States. Its gaming IP includes tools for marketing, acquisition, retention and monetization of users. Its platform can be accessed through desktop and mobile applications.

Golden Matrix earlier entered into a definitive distribution agreement with Red Label Technology to expand the number of gaming operators being serviced by Golden Matrix in the Asia Pacific region. Red Label Technology is an Asian-based company. It is owned and operated by a team of experienced social gaming entrepreneurs with extensive distribution channels throughout Asia.

Red Label will be introducing its gaming operator clients/contacts to Golden Matrix’s New Generation GM-X System. This System is a state-of-the-art gaming platform. It incorporates an artificial intelligence (AI) component and a module that supports seamless integration with Sportsbooks and e-Sports.

Golden Matrix Group announced in August of this year that it launched and went live with its first four proprietary slot games. They are basic traditional Chinese Slot Games. Each game depicts one of the four seasons. They represent the first units of an exclusive Golden Matrix portfolio of games to be called GM Slots.

In September 2018, Golden Matrix announced it expanded its game content with the addition of a Gaming Master Portfolio (GMP) of 32 innovative games on popular themes, including Chinese legends. GMP is already featured on the Company’s state-of-the-art GM-X platform. This makes it available to all gaming operator clients and, subsequently, to greater than one million active players within their networks.

Recently, Golden Matrix announced that for Q1 ended October 31, 2018, it recorded Net Income of $331,999. This is in comparison to a Net Loss of $458,043 in Q1 ended October 31, 2017. First quarter 2019 Revenues of $638,695 represent a 25 percent increase in revenues of $510,656 in Q4 2018 and a 2,029 percent increase in Revenues of $30,000 in the comparable year-ago period.

Golden Matrix Group, Inc. (GMGI), closed Thursday's trading session at $0.0012, up 9.09%, on 2,747,169 volume with 7 trades. The average volume for the last 3 months is 5,830,615 and the stock's 52-week low/high is $0.00019/$0.0028.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, ResearchPool, 4-Traders, Midas Letter, Daily Marijuana Observer, Weed Newswire, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, Wallet Investor, The Street, InvestorsHub, Business Insider, Investing News, Cannabis Newswire, Investors Hangout, Stockhouse, Barchart, Primed Equities, TradingView, and Marketwired reported earlier on Beleave, Inc. (BLEVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. In addition, the Company has patient services clinics operating across Ontario under the Medi-Green brand. Its wholly-owned subsidiary is Beleave Kannabis Corp. Beleave’s shares trade on the OTC Markets’ OTCQX.

Beleave’s goal is to provide a consistent, reliable and standardized product to suit the requirements of every person. The Company focuses on green initiatives. It grows its plants using no pesticides. Moreover, its facilities host a large-scale, commercial, solar installation that significantly offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

The Company’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain called Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

Beleave earlier closed on the acquisition of the Medi-Green Cannabis Clinic Network. London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth.

Beleave announced in July 2018 the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. The acquisition follows important news of Seven Oaks branded cannabis products being selected by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals anticipated to generate initial revenues of greater than $2,900,000. Beleave will offer Seven Oaks-branded cannabis flower, pre-rolls, as well as oils.

Recently, Beleave announced that it secured genetics acquisition agreements for a wide array of cannabis seed varieties from varied lineages. There will be 90 new varieties introduced in the coming year. These have been chosen to cover the entire spectrum of low, intermediate, and high THC and CBD profiles. The list includes well-known classic Sativa and Indica varieties with applications for medical and adult recreational markets.

Beleave has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market in 2019. The Company’s Hamilton, Ontario laboratory is undergoing expansion to make room for methods to formulate cannabis extracts into soluble, flavorless powders, sugar crystals, and syrups for use in beverages and food products utilizing stability-enhancing techniques for prolonged shelf-life.

Beleave’s Q2 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time). The call will be hosted by Mr. Andrew T. Wnek, Chairman and Chief Executive Officer, Bojan Krasic, President and Chief Financial Officer, and select members of the Senior Management Team.

Beleave, Inc. (BLEVF), closed Thursday's trading session at $0.0974, up 2.53%, on 348,891 volume with 80 trades. The average volume for the last 3 months is 421,191 and the stock's 52-week low/high is $0.05/$0.3114.

chart

Fiore Gold Ltd. (FIOGF)

Investors Hangout, OTC Markets, TradingView, Investorx, Stockhouse, Stockwatch, Energy and Gold, Stock Orange, Barchart, Dividend Investor, WatchDog Stocks, and Pinnacle Digest reported earlier on Fiore Gold Ltd. (FIOGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer listed on the OTCQB. The Company has the producing Pan Mine in Nevada. In addition, it has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado.

The Company’s aim is to build a new mid-tier mining company in the world’s foremost mining jurisdictions. Fiore Gold’s initial objective is on becoming an 150,000-ounce/year gold producer. Concerning North American Projects, Fiore Gold’s assets include the producing Pan Mine near Eureka, Nevada. Assets additionally include the nearby Gold Rock exploration project. Fiore also controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. Pan consists of three main zones of mineralization that has now been traced for more than 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton). Fiore Gold earlier announced the commencement of exploration drilling at its Pan Mine, as part of a longer-term program intended to expand the resource and reserve base at Pan.

Regarding South American Properties, the Company has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property consists of 13 mining claims totaling 3,400 hectares. It is roughly 130 kilometers southeast of Antofagasta, Chile.

The Cerro Tostado (South America) project consists of five concessions totaling about 1,500 ha situated in Region II approximately 125 km southeast of Antofagasta. The Rio Loa property is in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is around 25 km south of Salares Norte.

At the beginning of November, Fiore Gold provided results from eight exploration drill holes recently completed at its 100 percent-owned Gold Rock Property, White Pine County, Nevada. The holes targeted three of nine earlier-identified target areas north of the Gold Rock resource area that lies about 8 km southeast of the Company's Pan Mine. At present, Gold Rock hosts an Indicated Resource of 238,700 gold ounces (9.0 million tonnes at 0.82 g/t gold), and an Inferred Resource of 180,900 gold ounces (7.8 million tonnes at 0.72 g/t gold).

All eight holes intercepted the targeted Joanna Limestone unit. Six of the eight holes encountered anomalous gold mineralization, including 6.1 m at 0.67 g/t gold in hole GR18-04. The mineralization encountered was mainlty seen in the altered Joanna Limestone. However, mineralization also extended into carbonates in the base of the overlying Chainman Formation and in some cases the top of the underlying Pilot Shale.

Fiore Gold Ltd. (FIOGF), closed Thursday's trading session at $0.2846, up 1.46%, on 39,697 volume with 19 trades. The average volume for the last 3 months is 75,753 and the stock's 52-week low/high is $0.157/$0.709.

chart

Beyond Commerce, Inc. (BYOC)

Zacks, Penny Stock Tweets, Tip Ranks, 4-Traders, GuruFocus, Stockopedia, OTC.Watch, TradingView, Morningstar, Stockhouse, InvestorsHub, YCharts, Street Insider, Market Screener, Wallet Investor, Simply Wall St, Financial Content, MarketWatch, Investors Hangout, Barchart, The Street, Insider Financial, Stockinvest, and OTC Markets reported on Beyond Commerce, Inc. (BYOC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Beyond Commerce, Inc. is a planned provider of B2B (Business to Business) internet marketing analytics, technologies, and related services. Its planned goal is to develop, acquire, and deploy disruptive strategic software technology, which will build on organic growth potential. In addition, its planned goal is to exploit cross-selling opportunities. Beyond Commerce has its corporate headquarters in Las Vegas, Nevada. The Company lists on the OTC Markets Group’s OTCQB.

Beyond Commerce operates as a holding enterprise that concentrates on “big data” companies in the international B2B Internet Marketing Analytics/Technology and Services space. The Company plans to provide a cohesive digital product and services platform. This is to provide clients with a single point of contact for their big data, marketing and related sales initiatives. Beyond Commerce’s emphasis is to develop, acquire, as well as deploy disruptive strategic software technology and market-changing business models via acquisition or organic growth.

This past August, Beyond Commerce announced that it was added to the LD Micro Index effective August 1, 2018. Mr. George Pursglove, Beyond Commerce Chairman and Chief Executive Officer, stated in August, "This is an exciting time for us as we continue to execute on business milestones which are translating into additional exposure in the capital markets and building on our goals for corporate transparency and credibility with stakeholders.

Moreover, in October, Beyond Commerce announced that it filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). The Form S-1 filing was made in connection with the Company’s intention to up-list it's securities to a national exchange. The Form S-1 includes the consolidated audited financial statements for the years ended December 31, 2017 and 2016. Also included are the condensed consolidated reviewed financial statements for the three and six month periods ended March 31, and June 30, 2018 and 2017.

Beyond Commerce, Inc. (BYOC), closed Thursday's trading session at $0.061235, up 1.63%, on 434,440 volume with 29 trades. The average volume for the last 3 months is 657,252 and the stock's 52-week low/high is $0.00255/$0.159.

chart

eWellness Healthcare Corp. (EWLL)

Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.

The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.

The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.

Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.

eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.

eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.

Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.

Recently, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.

eWellness Healthcare Corp. (EWLL), closed Thursday's trading session at $0.14, up 3.70%, on 566,039 volume with 71 trades. The average volume for the last 3 months is 531,256 and the stock's 52-week low/high is $0.045/$0.3389.

chart

CurAegis Technologies, Inc. (CRGS)

StreetInsider, WalletInvestor, 4-Traders, Morningstar, InvestorsHub, MarketWatch, Stockhouse, YCharts, GuruFocus, TheHotPennyStocks, CapitalCube, Penny Fix, Barchart, Hot Copper, OTC Markets, Simply Wall St, TradingView, Business Insider, and OTC Research reported on CurAegis Technologies, Inc. (CRGS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions - its CURA Division and its Aegis Division.  CurAegis is currently centering on commercialization strategies in different technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. CurAegis Technologies is based in Rochester, New York.

The CURA System comprises hardware and software that measures many metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the decrease in a person’s alertness and to train persons on how to improve alertness levels. The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness.

CurAegis Technologies completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company earlier said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The Z-Coach e-learning tool was acquired by CurAegis Technologies in September of 2015. The first of six Z-Coach e-learning modules, Z-Coach Aviation, was designed for aviation professionals.

Additionally, the Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.

Regarding the Aegis Division’s Aegis Pump and Motor, it has eliminated the rotating piston group (the cylinders are stationary). This makes the pump very robust and easy to manufacture. The Company’s patented valving has been integrated to increase efficiencies at peak and off peak operation.

Concerning the CURA System, CurAegis Technologies is on schedule to have its system set for shipments in Q3. Moreover, concerning Aegis Pumps and Motor, the new motor is in development and the Company’s prototype is scheduled to be available this month.

CurAegis Technologies, Inc. (CRGS), closed Thursday's trading session at $0.22, down 4.35%, on 3,102 volume with 5 trades. The average volume for the last 3 months is 17,052 and the stock's 52-week low/high is $0.10/$0.49.

chart

The QualityStocks Company Corner

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSXV:RIV.V) (OTC:CNPOF) was featured today in a report by NetworkNewsWire covering why this unique investment and operating platform is “One to Watch.” Also today, NetworkNewsWire released a report on the company detailing how Canopy Growth (NYSE: CGC) is near to spinning off its new financial investment company, Canopy Rivers, into a publicly traded firm, which will pursue investment opportunities in the growing cannabis sector.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $5.86, up 6.74%, on 1,541,784 volume with 2,189 trades. The average volume for the last 3 months is 417,820 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) announced that yesterday, January 30, it executed an arm's length definitive agreement to acquire control of ZLJT LLC & Arizona Natural Pain Solutions Inc, collectively referred to as "Desert Rose". Desert Rose holds a license for a vertically-integrated operation in Arizona, including retail, cultivation & infusion (kitchen). As consideration for the membership interests, GGB will pay an aggregate purchase price of USD$12,350,000 (CAN$16,292,120) in cash.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.04, up 4.66%, on 225,910 volume with 707 trades. The average volume for the last 3 months is 167,108 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSXV: FLWR) (OTC: FLWPF) (“Flowr” or the “Company”), a Canadian licenced producer of premium cannabis products, announced today it will begin selling a wide selection of cannabis cultivars in both clone and seed form in the second quarter of this year.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $4.35, up 9.02%, on 110,396 volume with 233 trades. The average volume for the last 3 months is 72,450 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH absorption platform will receive a significant injection of R&D financing under an investment agreement that wholly owned subsidiary Lexaria Nicotine LLC has entered into with a large tobacco partner. LXRP has initially received $1 million toward its research on nicotine consumer products that use DehydraTECH (http://nnw.fm/A0iyv). Also today, CannabisNewsWire released a report on the company detailing how LXRP is focused on licensing disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. To view the full publication, titled “Outside Investment, New Technology Support Growing Cannabis Industry,” visit: http://cnw.fm/H3q7r.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.49, off by 1.32%, on 599,153 volume with 269 trades. The average volume for the last 3 months is 178,085 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture. The Company's portfolio includes its wholly-owned subsidiary and multi-award-winning brand, 7ACRES. 

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.62, up 9.46%, on 632,267 volume with 529 trades. The average volume for the last 3 months is 364,163 and the stock's 52-week low/high is $0.85/$2.11.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Hemp-cultivated cannabinoid innovator Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) this morning provided a corporate update that reviewed completed milestones and ongoing strategic initiatives. To view the full press release, visit: http://nnw.fm/g4zpS.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.4242, up 8.24%, on 121,358 volume with 63 trades. The average volume for the last 3 months is 34,977 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI), (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that it has signed a Royalty Agreement with QVI, Inc. which stands for, Quality, Value, Integrity, doing business as “The Galley”, a cannabis infused product manufacturer located in Sonoma County, California.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1462, up 8.14%, on 66,273 volume with 21 trades. The average volume for the last 3 months is 40,731 and the stock's 52-week low/high is $0.0577/$0.71.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions Inc. (OTCQB: SGSI), a leading single-source provider of end-to-end, next-generation wireless and wireline networks, recently announced that its stock has been uplisted and approved for trading on the OTCQB Venture Marketplace. The company provides professional service solutions to the service provider and corporate enterprise markets.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.13, up 8.33%, on 10,000 volume with 2 trades. The average volume for the last 3 months is 27,351 and the stock's 52-week low/high is $0.0813/$2.59.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

With the incidence of breast cancer expected to increase worldwide, the therapeutic market for this particular ailment is also set to grow at a CAGR of eight percent through 2023, according to industry reports (http://nnw.fm/3Alp8). Companies such as BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) will be leading the way, as the development of new treatment solutions is expected to be a primary factor contributing to the market’s growth.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.071, up 5.97%, on 715 volume with 1 trade. The average volume for the last 3 months is 17,839 and the stock's 52-week low/high is $0.049/$0.135.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske high-grade Iron Ore Project located in Krivyi Rih, Ukraine, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW") to help raise awareness of this great investment opportunity.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.049, up 25.64%, on 40,000 volume with 3 trades. The average volume for the last 3 months is 6,060 and the stock's 52-week low/high is $0.0285/$0.094.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB:PLPRF) (the “Company” or “PLUS™”) today announced that, according to BDS Analytics (bdsanalytics.com) retail sales data, during Q4 2018, PLUS again secured its position as the #1 best-selling cannabis-infused edibles brand in California and saw its lead over the #2 brand widen over the prior quarter.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.535, off by 1.63%, on 27,580 volume with 69 trades. The average volume for the last 3 months is 3,680 and the stock's 52-week low/high is $2.81/$5.00.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Uptick Newswire Stock Day Podcast welcomed Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) (“Sunniva” or the “Company“) a North American provider of cannabis products and services. Their Co-Founder, President, Chief Strategy Officer & Director, Leith Pedersen, talked with Stock Day’s Everett Jolly. Also today, the company announced changes to its California leadership team for the growth of the Sunniva-branded product lines to be sold throughout 2019.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $3.45, off by 5.37%, on 100,013 volume with 202 trades. The average volume for the last 3 months is 93,114 and the stock's 52-week low/high is $2.035/$11.93.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in a report examining how, after 2018 took some wind out of the sales for the emerging cannabis industry, early 2019 has reinvigorated a market that ArcView has said could reach $57 Billion by 2027.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.68, off by 1.83%, on 1,215,353 volume with 1,628 trades. The average volume for the last 3 months is 1,006,862 and the stock's 52-week low/high is $1.61/$7.89.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (NUGS) was highlighted today in a report by Financialnewsmedia.com, which discussed how NUGS recently announced its plan to break ground on a 6-acre canopy cultivation site in Northern California which will be known as The NUGS Farm. Complimentary to this land acquisition, the Company has obtained from the State of California over 20 licenses for cannabis manufacturing, distribution and cultivation.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.55, off by 3.12%, on 134,240 volume with 169 trades. The average volume for the last 3 months is 90,195 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.